Membership

Prospective member organizations should contact THSNA at info@thsna.org for instructions as to the application process.

Fundamental Criteria for THSNA Membership (all 3 must be satisfied)

• Member Organization contributes to the promotion of THSNA and/or the THSNA Summit with the following actions:
• Posting THSNA Societies and Summit information on organization website, including a link to the THSNA website.
• Sending e-mail notifications to members about THSNA activities and Summit
• Contributes to the organization of the THSNA Summit, unless the organization does not qualify for summit surplus sharing.
• Reviews THSNA Summit abstracts (as appropriate, based on the expertise within a given member organization)

• Member Organization is involved in an activity that has a direct activity scientific, educational or mentoring, or direct patient advocacy mandate related to thrombosis/hemostasis.
• Examples of scientific, educational and direct patient advocacy activities are provided in Appendix 1.

• Member Organization is a nationally registered not-for-profit organization and can receive funding from industry/private sources and/or government sources.
• Member organization must fully disclose any potential conflict of interest with pharmaceutical companies and other potential sources of funding.

Criteria for Summit Surplus Sharing*

Pertains to Member Organizations that hold an annual meeting or a meeting that coincides with a THSNA Summit year.

• Holds a national meeting in the same year as THSNA Summit with invitation and/or submitted abstract-based presentations, which cover broad topics with a goal of advancing scientific and clinical knowledge within the scope of the organization and will defer such a meeting on a THSNA Summit year (to avoid splitting of health care professional participation to both meetings)**.

OR

• Holds a national meeting in the same year as the THSNA Summit and is not expected to appreciably draw attendees from the THSNA Summit (i.e., expected attendance of health care professionals <150, or by its content, the meeting is not expected to compete with the THSNA Summit).

OR

• Holds a meeting that is not national and is not expected to appreciably draw attendees from the THSNA Summit.

*Member organization may participate in the THSNA Summit Meeting even if they are not eligible for the share plan.
**If a member organization plans to hold a national meeting that would potentially draw attendees away from the THSNA Summit (i.e., >150 health care professional attendees), this can be allowed with the proviso that this organization is acknowledged/participates in the Summit but does not qualify to receive funds from the Summit share plan.

 

Appendix 1. Examples of scientific, educational and/or direct patient advocacy

• Involved in the education of health care professionals in the areas of thrombosis and hemostasis and related diagnosis and/or treatment through written material, educational programs and/or other activities.
• Involved in the development of clinical practice guidelines or expert-based clinical guidance.
• Involved in the support of trainees.
• Involved in direct patient advocacy, by lobbying pertinent stakeholders (e.g., government agencies) to for funding and/or related support.
• Involved in increasing awareness to the general public of thrombosis and/or hemostasis related diseases and conditions.
• Involved in data collection for research and best clinical care.